actuarially appropriate

Premium rates expected to cover anticipated losses and a reasonable reserve based on valid reasoning, an examination of available risk data (which for new products may be scarce but must still be of sufficient quality and quantity to reasonably determine the anticipated losses), or thorough knowledge or experience of the expected value of future costs associated with the risk to be transferred.

Authorization Path: